Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Cash (2023 - 2025)

Fractyl Health's Change in Cash history spans 3 years, with the latest figure at $3.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 122.58% year-over-year to $3.9 million, compared with a TTM value of $14.1 million through Dec 2025, down 58.53%, and an annual FY2025 reading of $14.1 million, down 58.53% over the prior year.
  • Change in Cash for Q4 2025 was $3.9 million at Fractyl Health, down from $55.4 million in the prior quarter.
  • The five-year high for Change in Cash was $88.2 million in Q1 2024, with the low at -$25.4 million in Q1 2025.
  • Average Change in Cash over 3 years is $2.7 million, with a median of -$11.5 million recorded in 2023.
  • Biggest YoY gain for Change in Cash was 1021.77% in 2024; the steepest drop was 207.67% in 2024.
  • Tracing GUTS's Change in Cash over 3 years: stood at -$11.3 million in 2023, then crashed by 52.33% to -$17.2 million in 2024, then skyrocketed by 122.58% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Change in Cash are $3.9 million (Q4 2025), $55.4 million (Q3 2025), and -$19.8 million (Q2 2025).